David Su is a founding managing partner at Matrix Partners China, focused primarily on Internet, software, deeptech and healthcare investments. David has been investing in China over the past two decades and some of his early stage investments include Didi Global, Xpeng (NYSE:XPEV), Baidu (NSDQ:BIDU), Bona Film (NSDQ:BONA), Focus Media (NSDQ:FMCN), Kanghui Medical (NYSE:KH), Kingfriend Biochemical (SS:603707), China Youzan (8083.HK), AAC Technologies (2018.HK), Heptagon (SIX:AMS). Before Matrix, David was a founding partner of TDF Capital and KPCB China. Prior to joining the venture capital industry, David worked at Lotus Development, IBM Software Group for seven years and was last responsible for Lotus’ software and services business in Greater China region. David graduated with a Bachelor of Applied Science in Computer Engineering from Nanyang Technological University, Singapore. David currently serves on the Board of Trustees for Nanyang Technological University and CapitaLand Investment Limited.
